RT Journal Article
SR Electronic
T1 Mathematical Mo Del with So Cial Distancing Parameter for Early Estimation of Covid-19 Spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20086611
DO 10.1101/2020.04.30.20086611
A1 Saroj Kumar Chandra
A1 Avaneesh Singh
A1 Manish Kumar Bajpai
YR 2020
UL http://medrxiv.org/content/early/2020/09/03/2020.04.30.20086611.abstract
AB COVID-19 is well known to everyone in the world. It has spread around the world. No vaccine or antiviral treatment is available till now. COVID-19 patients are increasing day by day. All countries have adopted social distancing as a preventive measure to reduce spread. It becomes necessary to estimate the number of peoples going to be affected with COVID-19 in advance so that necessary arrangements can be done. Mathematical models are used to provide early disease estimation based on limited parameters. In the present manuscript, a novel mathematical model with a social distancing parameter has been proposed to provide early COVID-19 spread estimation. The model has been validated with real data set. It has been observed that the proposed model is more accurate in spread estimation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work has been supported by a grant received from the Ministry of Education, Government of India under the Scheme for the Promotion of Academic and Research Collaboration (SPARC), 2019Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm that all guidlines have been followed and necessary IRB and/or ethics committee approvals have been obtained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode will be available on request